Reactogenicity to a Live Attenuated Varicella Vaccine in Canadian Children

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

In countries where routine varicella vaccination is implemented, it is usually given at the same age as that recommended for measles-mumps-rubella (MMR) vaccination. A combined multivalent measles-mumps-rubella-varicella (MMRV) vaccine would offer the convenience of a single injection and facilitate implementation of varicella vaccination into routine childhood immunisation schedules. We evalua...

A review of prophylactic measure against brucellosis in human with a live attenuated vaccine

Experimental study of a further attenuated live measles vaccine of the Sugiyama strain in Iran

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents

BACKGROUND Influenza affects all age groups and is common in children. Between 15% and 42% of preschool- and school-aged children experience influenza each season. Recently, intranasal live attenuated influenza vaccine, trivalent (LAIV) has been approved in Canada. OBJECTIVE The objective of this study was to determine the cost-effectiveness of LAIV compared with that of the injectable inacti...

Development of a New Live Attenuated Mumps Virus Vaccine in Human Deploid Cells